コンテンツへスキップ
Merck
  • Golgi fragmentation and sphingomyelin transport to Chlamydia trachomatis during penicillin-induced persistence do not depend on the cytosolic presence of the chlamydial protease CPAF.

Golgi fragmentation and sphingomyelin transport to Chlamydia trachomatis during penicillin-induced persistence do not depend on the cytosolic presence of the chlamydial protease CPAF.

PloS one (2014-07-30)
Stephanie Dille, Katharina Herbst, Larisa Volceanov, Thilo Nölke, Oliver Kretz, Georg Häcker
要旨

Chlamydia grows inside a cytosolic vacuole (the inclusion) that is supplied with nutrients by the host through vesicular and non-vesicular transport. It is unclear in many respects how Chlamydia organizes this transport. One model posits that the Chlamydia-induced fragmentation of the Golgi-apparatus is required for normal transport processes to the inclusion and for chlamydial development, and the chlamydial protease CPAF has been controversially implicated in Golgi-fragmentation. We here use a model of penicillin-induced persistence of infection with Chlamydia trachomatis to test this link. Under penicillin-treatment the inclusion grew in size for the first 24 h but after that growth was severely reduced. Penicillin did not reduce the number of infected cells with fragmented Golgi-apparatus, and normal Golgi-fragmentation was found in a CPAF-deficient mutant. Surprisingly, sphingomyelin transport into the inclusion and into the bacteria, as measured by fluorescence accumulation upon addition of labelled ceramide, was not reduced during penicillin-treatment. Thus, both Golgi-fragmentation and transport of sphingomyelin to C. trachomatis still occurred in this model of persistence. The portion of cells in which CPAF was detected in the cytosol, either by immunofluorescence or by immune-electron microscopy, was drastically reduced in cells cultured in the presence of penicillin. These data argue against an essential role of cytosolic CPAF for Golgi-fragmentation or for sphingomyelin transport in chlamydial infection.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
重炭酸ナトリウム, ACS reagent, ≥99.7%
Sigma-Aldrich
重炭酸ナトリウム, powder, BioReagent, for molecular biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
重炭酸ナトリウム, ReagentPlus®, ≥99.5%, powder
Sigma-Aldrich
尿素, powder, BioReagent, for molecular biology, suitable for cell culture
Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
モノクロナール抗β-アクチン マウス宿主抗体, clone AC-15, ascites fluid
Sigma-Aldrich
重炭酸ナトリウム, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.7%
Sigma-Aldrich
尿素 溶液, BioUltra, ~8 M in H2O
Sigma-Aldrich
四酸化オスミウム, ReagentPlus®, 99.8%
Supelco
Urea, 8 M (after reconstitution with 16 mL high purity water)
Sigma-Aldrich
尿素, ACS reagent, 99.0-100.5%
Sigma-Aldrich
四酸化オスミウム 溶液, 4 wt. % in H2O
Sigma-Aldrich
尿素, BioXtra, pH 7.5-9.5 (20 °C, 5 M in H2O)
Sigma-Aldrich
重炭酸ナトリウム, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder
Sigma-Aldrich
四酸化オスミウム 溶液, suitable for electron microscopy, 4% in H2O
Sigma-Aldrich
四酸化オスミウム 溶液, 2.5 wt. % in tert-butanol
Sigma-Aldrich
栄養混合物 F-12ハム, Kaighn′s Modification, with L-glutamine, without sodium bicarbonate, powder, suitable for cell culture
Sigma-Aldrich
尿素, suitable for electrophoresis
Sigma-Aldrich
尿素, BioUltra, for molecular biology, 99% (T)
Sigma-Aldrich
尿素, ReagentPlus®, ≥99.5%, pellets
USP
重炭酸ナトリウム, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
重炭酸ナトリウム, BioXtra, 99.5-100.5%
Sigma-Aldrich
四酸化オスミウム, ACS reagent, ≥98.0%
USP
尿素, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
四酸化オスミウム 溶液, suitable for electron microscopy, 2% in H2O
Sigma-Aldrich
四酸化オスミウム, Sealed ampule.
Sigma-Aldrich
重炭酸ナトリウム, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%
Sigma-Aldrich
尿素 溶液, 40 % (w/v) in H2O
Sigma-Aldrich
尿素, meets USP testing specifications
Sigma-Aldrich
インスリン ウシ膵臓由来, Hybri-Max, powder, suitable for hybridoma